Beta Bionics Financial Statements
NASDAQ: BBNXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Beta Bionics revenue and earnings
In fiscal 2025, Beta Bionics generated $100.3 million in revenue, up 53.9% from fiscal 2024, its 2nd consecutive year of revenue growth. Beta Bionics reported a net loss of $73.2 million, compared with a loss of $54.8 million a year earlier. Gross margin was 55.4% (up from 55.1%) and operating margin -71.5%.
Diluted earnings per share came in at -$1.81. Over the last 2 fiscal years, BBNX's revenue has grown at a 189.1% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Beta Bionics income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Revenue | 100.25M | 65.12M | 11.99M |
| Revenue growth (YoY) | +53.94% | +442.93% | — |
| Cost of Revenue | 44.71M | 29.24M | 5.69M |
| Gross Profit | 55.54M | 35.89M | 6.31M |
| Operating Expenses | 127.22M | 81.14M | 42.16M |
| Research & Development | 34.79M | 26.18M | 17.94M |
| Selling, General & Admin | 92.43M | 54.95M | 24.21M |
| Operating Income | -71.68M | -45.25M | -35.85M |
| Other Income (Expense) | -1.52M | -9.51M | -8.25M |
| Income Tax | 0 | 0 | — |
| Net Income | -73.20M | -54.76M | -44.10M |
| Net Income growth (YoY) | — | — | — |
| EPS (Basic) | -1.81 | -8.60 | -8.31 |
| EPS (Diluted) | -1.81 | -8.60 | -8.31 |
| Shares Outstanding (Basic) | 40.53M | 6.37M | 5.30M |
| Shares Outstanding (Diluted) | 40.53M | 6.37M | 5.30M |
| EBITDA | -70.11M | -44.10M | -34.62M |
| Gross Margin | 55.40% | 55.11% | 52.59% |
| Operating Margin | -71.50% | -69.48% | -298.87% |
| Net Margin | -73.02% | -84.08% | -367.64% |
This table shows 3 annual periods of Beta Bionics's income statement, from FY 2025 back to FY 2023, across 18 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow BBNX's reporting calendar. What is a income statement?